{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:11:18Z","timestamp":1787847078798,"version":"build-2784847793"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Duchenne muscular dystrophy (DMD) and Becker muscular dystrophy (BMD) are rare X-linked neuromuscular disorders that typically begin in childhood and progress to functional decline, loss of ambulation, and early death due to cardiac or respiratory failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>To describe the landscape of DMD and BMD in Qatar, including demographics, genetics, disease progression, risk factors, co-morbidities, and outcomes in patients aged 3\u201330 years, and compare findings with international data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We retrospectively reviewed records of all genetically confirmed or biopsy-supported cases of DMD and BMD between 2018 and 2024 at Sidra Medicine, the sole pediatric tertiary center in Qatar.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 37 symptomatic patients (36 DMD, 1 BMD), 36 were male and one was a symptomatic female. The mean age was 18 years (range 3\u201330). At diagnosis, median age was 3.0 years. Twenty-two (59%) had orthopedic complications (scoliosis, contractures), 9 (24%) could still run, and 12 (32%) could climb stairs. Corticosteroids were prescribed in 14 patients (38%), most commonly deflazacort and prednisone. Cardiac medications were started in 7 patients (19%) around age 10. CK was elevated in 36\/37 (range: 2,300\u201345,000 U\/L). Epilepsy was documented in 3 patients; 3 had autism and 1 had ADHD. Genetic mutations included deletions (69%), duplications (11%), and point mutations (19%). Seven patients had mutations affecting Dp140\/Dp71 isoforms and cognitive impairment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our cohort reveals earlier diagnosis but lower life expectancy compared to international standards, likely due to lower corticosteroid and cardioprotective use. The findings support the need for strengthened multidisciplinary and early genetic-based interventions in Qatar<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1569505","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T14:43:25Z","timestamp":1754059405000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Patient demographics, clinical characteristics and genetic mutations of DMD and BMD patients in Qatar Epidemiological and genetic profile of Duchenne muscular dystrophy and Becker muscular dystrophy patients in Qatar: a retrospective cohort study"],"prefix":"10.3389","volume":"13","author":[{"given":"Mohammad","family":"Sawahreh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Al-Maadid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Omer","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawfeg Ben","family":"Omran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud Fawzi","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.nmd.2014.03.008","article-title":"A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy","volume":"24","author":"Mah","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"B3","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.neubiorev.2013.03.016","article-title":"Neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: a review","volume":"37","author":"Snow","year":"2013","journal-title":"Neurosci Biobehav Rev"},{"key":"B4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/mus.20586","article-title":"Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the Reading-frame rule","volume":"34","author":"Aartsma-Rus","year":"2006","journal-title":"Muscle Nerve"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1093\/hmg\/ddw210","article-title":"Dystrophin contains multiple independent membrane-binding domains","volume":"25","author":"Zhao","year":"2016","journal-title":"Hum Mol Genet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ejpn.2017.02.007","article-title":"Assessing mental health in boys with Duchenne muscular dystrophy: emotional, behavioural and neurodevelopmental profile in an Italian clinical sample","volume":"21","author":"Colombo","year":"2017","journal-title":"Eur J Paediatr Neurol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jmedgenet-2015-103387","article-title":"The importance of genetic diagnosis for Duchenne muscular dystrophy","volume":"53","author":"Aartsma-Rus","year":"2016","journal-title":"J Med Genet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2217\/nmt-2019-0002","article-title":"Current management of Duchenne muscular dystrophy in the Middle East: expert report","volume":"9","author":"Jumah","year":"2019","journal-title":"Neurodegener Dis Manag"},{"key":"B10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-021-00248-3","article-title":"Duchenne muscular dystrophy","volume":"7","author":"Duan","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"B11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3233\/JND-160185","article-title":"European cross-sectional survey of current care practices for duchenne muscular dystrophy reveals regional and age-dependent differences","volume":"3","author":"Vry","year":"2016","journal-title":"J Neuromuscul Dis"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1020059","DOI":"10.3389\/fped.2022.1020059","article-title":"Patient demographics and characteristics from an ambispective, observational study of patients with duchenne muscular dystrophy in Saudi Arabia","volume":"10","author":"AlSaman","year":"2022","journal-title":"Front Pediatr"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.2217\/cer-2019-0086","article-title":"Ataluren use in patients with nonsense mutation Duchenne muscular dystrophy: patient demographics and characteristics from the STRIDE registry","volume":"8","author":"Francesco","year":"2019","journal-title":"J Comp Eff Res"},{"key":"B14","doi-asserted-by":"publisher","first-page":"e2304","DOI":"10.1212\/WNL.0000000000012910","article-title":"Life expectancy in Duchenne muscular dystrophy","volume":"97","author":"Broomfield","year":"2021","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.rehab.2013.06.002","article-title":"Evolution of life expectancy of patients with Duchenne muscular dystrophy at AFM Yolaine de Kepper centre between 1981 and 2011","volume":"56","author":"Kieny","year":"2013","journal-title":"Ann Phys Rehabil Med"},{"key":"B16","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0140-6736(17)32160-8","article-title":"Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study","volume":"391","author":"McDonald","year":"2018","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"716424","DOI":"10.3389\/fped.2021.716424","article-title":"Case report: the genetic diagnosis of Duchenne muscular dystrophy in the Middle East","volume":"9","author":"Alghamdi","year":"2021","journal-title":"Front Pediatr"},{"key":"B18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3390\/jpm10040241","article-title":"Genotype\u2013phenotype correlations in Duchenne and Becker muscular dystrophy patients from the Canadian neuromuscular disease registry","volume":"10","author":"Lim","year":"2020","journal-title":"J Pers Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12883-022-02687-1","article-title":"Characteristics of disease progression and genetic correlation in ambulatory Iranian boys with Duchenne muscular dystrophy","volume":"22","author":"Zamani","year":"2022","journal-title":"BMC Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1136\/jnnp-2014-309405","article-title":"The NorthStar ambulatory assessment in Duchenne muscular dystrophy: considerations for the design of clinical trials","volume":"87","author":"Ricotti","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"B21","doi-asserted-by":"publisher","first-page":"e0221097","DOI":"10.1371\/journal.pone.0221097","article-title":"Categorising trajectories and individual item changes of the north star ambulatory assessment in patients with Duchenne muscular dystrophy","volume":"14","author":"Muntoni","year":"2019","journal-title":"PLoS One"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e108038","DOI":"10.1371\/journal.pone.0108038","article-title":"Screening of Duchenne muscular dystrophy (DMD) mutations and investigating its mutational mechanism in Chinese patients","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2350-14-29","article-title":"MLPA-based genotype\u2013phenotype analysis in 1053 Chinese patients with DMD\/BMD","volume":"14","author":"Yang","year":"2013","journal-title":"BMC Med Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1017\/S0317167100011896","article-title":"A population-based study of dystrophin mutations in Canada","volume":"38","author":"Buckley","year":"11","journal-title":"Can J Neurol Sci"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1569505\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T14:43:25Z","timestamp":1754059405000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1569505\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":24,"alternative-id":["10.3389\/fped.2025.1569505"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1569505","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"article-number":"1569505"}}